Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Jin‐San Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4436-9593; OpenAlex author ID A5048721439. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 6)
Trials
0
Grants
0
Labs led
2
Collaborators
50
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 2 papers · 2016: 3 papers · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 4 papers · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 16

  1. ESE1/AGR2 axis antagonizes TGF-β-induced epithelial-mesenchymal transition in low-grade pancreatic cancer. Last author DOI 10.1002/cam4.5397↗
  2. Yap1-2 Isoform Is the Primary Mediator in TGF-β1 Induced EMT in Pancreatic Cancer. Last author DOI 10.3389/fonc.2021.649290↗
  3. EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6. Co-author DOI 10.1158/0008-5472.can-20-0672↗
  4. An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness. Last author DOI 10.3389/fcell.2020.00287↗
  5. Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness. Last author DOI 10.3389/fcell.2020.594589↗
  6. The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy. Last author DOI 10.7150/thno.42795↗
  7. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Co-author DOI 10.1111/cpr.12568↗
  8. Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response. Co-author DOI 10.1158/1078-0432.ccr-19-0799↗
  9. Fibroblast Growth Factor 10 in Pancreas Development and Pancreatic Cancer. Last author DOI 10.3389/fgene.2018.00482↗
  10. NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation. First author DOI 10.1155/2016/5272498↗
  11. SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway. Co-author DOI 10.1158/1078-0432.ccr-15-1760↗
  12. GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression. Co-author DOI 10.1158/1535-7163.mct-15-0309↗
  13. Nuclear FAM21 participates in NF-κB-dependent gene regulation in pancreatic cancer cells. Co-author DOI 10.1242/jcs.161513↗
  14. Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity. Co-author DOI 10.15252/embj.201489574↗
  15. Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D. Co-author DOI 10.1158/2159-8290.cd-13-0593↗
  16. Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer. Co-author DOI 10.1053/j.gastro.2011.11.001↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel D. Billadeau · 11 shared papers, 2012–2020 · strength 0.67
  2. Meiyu Quan · 5 shared papers, 2020–2023 · strength 0.55
  3. Jiayu Liu · 3 shared papers, 2020–2021 · strength 0.30
  4. Volker Ellenrieder · 6 shared papers, 2012–2020 · strength 0.29
  5. Zhenkun Lou · 3 shared papers, 2020 · strength 0.28
  6. Qiang Guo · 3 shared papers, 2020 · strength 0.28
  7. Elisabeth Heßmann · 5 shared papers, 2014–2020 · strength 0.26
  8. Huijing Xu · 2 shared papers, 2020–2023 · strength 0.25
  9. Shiv K. Singh · 5 shared papers, 2012–2020 · strength 0.23
  10. Albrecht Neeße · 4 shared papers, 2014–2020 · strength 0.20
  11. Alexander Otto König · 4 shared papers, 2014–2016 · strength 0.17
  12. Li Ding · 2 shared papers, 2019–2020 · strength 0.17
  13. Jie Wang · 1 shared paper, 2023 · strength 0.16
  14. Jochen Gaedcke · 2 shared papers, 2015–2020 · strength 0.12
  15. Chao Gao · 1 shared paper, 2021 · strength 0.11
  16. Sandra Baumgart · 3 shared papers, 2012–2016 · strength 0.11
  17. Thomas Mathias Gress · 3 shared papers, 2012–2016 · strength 0.11
  18. Rodrick Ndlovu · 1 shared paper, 2018 · strength 0.11
  19. Rongtao Zhou · 1 shared paper, 2019 · strength 0.10
  20. Chun‐Bo Teng · 1 shared paper, 2019 · strength 0.10
  21. Liang Jin · 1 shared paper, 2019 · strength 0.10
  22. Yi Pan · 1 shared paper, 2019 · strength 0.10
  23. Ze Yu · 1 shared paper, 2019 · strength 0.10
  24. Sheng Tai · 1 shared paper, 2019 · strength 0.10
  25. Wei Wang · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.